# Rivaroxaban Sotorasib Interaction Study

> **NCT06314763** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Drug Drug Interaction Study

## Interventions

- **DRUG:** Rivaroxaban 20mg
- **DRUG:** Sotorasib 960mg

## Key facts

- **NCT ID:** NCT06314763
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-09
- **Primary completion:** 2024-03-21
- **Final completion:** 2024-03-21
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06314763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06314763, "Rivaroxaban Sotorasib Interaction Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06314763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*